USMJ Annual Revenue Increases 44% to $742,000 With Gross Margin Over 50%

Dallas, TX – November 03, 2017 -- InvestorsHub NewsWire -- North American Cannabis Holdings, Inc. (USMJ) has released its annual financial report for the fiscal year end 2017. The company reported year to year revenue growth of 44% with revenue increasing from $515,000 in 2016 to $742,000. The company reported a gross margin of $408,000 reflecting a gross margin rate of over 50%. The company plans to continue investing in high margin top line growth and anticipates ongoing operating losses as increased expenses precede increased revenue growth. The USMJ 2017 annual report has been published on OTC Markets. Management plans to publish a shareholder update next week on the company’s website with more insight into the annual report and future plans for growth.

As of the filing of this press release, OTC Markets has not yet updated USMJ to “current” status. USMJ management anticipates the “current” update imminently.

Learn more about USMJ, its parent company, ACI, and ACI’s other holdings to include PURA by visiting: http://www.aciconglomerated.com/

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

ACI, USMJ and PURA contact info:
Steven Rash
info@aciconglomerated.com
+1-800-861-1350
https://www.aciconglomerated.com/contact/